rs6489957

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_181486.4(TBX5):​c.1281C>T​(p.Ser427=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00301 in 1,614,076 control chromosomes in the GnomAD database, including 117 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.016 ( 60 hom., cov: 33)
Exomes 𝑓: 0.0016 ( 57 hom. )

Consequence

TBX5
NM_181486.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.488
Variant links:
Genes affected
TBX5 (HGNC:11604): (T-box transcription factor 5) This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of developmental processes. This gene is closely linked to related family member T-box 3 (ulnar mammary syndrome) on human chromosome 12. The encoded protein may play a role in heart development and specification of limb identity. Mutations in this gene have been associated with Holt-Oram syndrome, a developmental disorder affecting the heart and upper limbs. Several transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant 12-114355808-G-A is Benign according to our data. Variant chr12-114355808-G-A is described in ClinVar as [Benign]. Clinvar id is 255491.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-114355808-G-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.488 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0544 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
TBX5NM_181486.4 linkuse as main transcriptc.1281C>T p.Ser427= synonymous_variant 9/9 ENST00000405440.7
TBX5NM_000192.3 linkuse as main transcriptc.1281C>T p.Ser427= synonymous_variant 9/9
TBX5NM_080717.4 linkuse as main transcriptc.1131C>T p.Ser377= synonymous_variant 8/8
TBX5XM_017019912.2 linkuse as main transcriptc.1329C>T p.Ser443= synonymous_variant 9/9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
TBX5ENST00000405440.7 linkuse as main transcriptc.1281C>T p.Ser427= synonymous_variant 9/91 NM_181486.4 P1Q99593-1
TBX5ENST00000310346.8 linkuse as main transcriptc.1281C>T p.Ser427= synonymous_variant 9/91 P1Q99593-1
TBX5ENST00000349716.9 linkuse as main transcriptc.1131C>T p.Ser377= synonymous_variant 8/81 Q99593-3

Frequencies

GnomAD3 genomes
AF:
0.0162
AC:
2467
AN:
152168
Hom.:
59
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0561
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00687
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000162
Gnomad OTH
AF:
0.0115
GnomAD3 exomes
AF:
0.00437
AC:
1097
AN:
250758
Hom.:
26
AF XY:
0.00321
AC XY:
436
AN XY:
135624
show subpopulations
Gnomad AFR exome
AF:
0.0590
Gnomad AMR exome
AF:
0.00309
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000109
Gnomad SAS exome
AF:
0.000131
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000141
Gnomad OTH exome
AF:
0.00261
GnomAD4 exome
AF:
0.00163
AC:
2386
AN:
1461790
Hom.:
57
Cov.:
33
AF XY:
0.00136
AC XY:
986
AN XY:
727210
show subpopulations
Gnomad4 AFR exome
AF:
0.0574
Gnomad4 AMR exome
AF:
0.00340
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000176
Gnomad4 SAS exome
AF:
0.000162
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000621
Gnomad4 OTH exome
AF:
0.00354
GnomAD4 genome
AF:
0.0163
AC:
2479
AN:
152286
Hom.:
60
Cov.:
33
AF XY:
0.0156
AC XY:
1165
AN XY:
74450
show subpopulations
Gnomad4 AFR
AF:
0.0563
Gnomad4 AMR
AF:
0.00686
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000162
Gnomad4 OTH
AF:
0.0113
Alfa
AF:
0.00933
Hom.:
15
Bravo
AF:
0.0190
Asia WGS
AF:
0.00289
AC:
10
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.000119

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpFeb 13, 2017Variant summary: The c.1281C>T (p.Ser427=) in TBX5 gene is a synonymous change that involves a non-conserved nucleotide. 5/5 programs in Alamut predict that this variant does not affect normal splicing, however no functional studies supporting this notion were published at the time of evaluation. The variant is present in the control population dataset of ExAC at frequency of 0.00545 (652/119626 chrs tested), predominantly in individuals of African origin (0.06092; 612/ 10046 chrs), including 17 homozygotes. The observed frequency exceeds the maximum expected allele frequency for a pathogenic variant in this gene (0.0000013), suggesting that it is a benign polymorphism. The variant of interest has been cited as Benign by several reputable databases/clinical laboratories. Taking together, the variant was classified as Benign. -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Holt-Oram syndrome Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Aortic valve disease 2 Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsAug 04, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.73
CADD
Benign
0.13
DANN
Benign
0.89

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs6489957; hg19: chr12-114793613; COSMIC: COSV59866470; API